MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market

MoonLake Immunotherapeutics (MLTX) Stock Investors

287 Followers
Based on 748,626 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold MLTX
On average, investors allocate 3.23% of their portfolios to MLTX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 748,626 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding MLTX

1.9%
Last 7
Days
12.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding MLTX, out of 748,626 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

MLTX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
1.64%
$62.50
Increased
0.98%
$38.71
Increased
5.13%
$38.71
Based on the activity of 14,214 investors who made their portfolios public
The table shows changes in MLTX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

MLTX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.76%
-0.97%
-1.77%
31.86B
Consumer Cyclical
Trade Desk
4.63%
-1.65%
+0.24%
45.21B
Technology
Zscaler
3.82%
-1.09%
+0.76%
27.41B
Technology
Microstrategy
7.07%
+0.13%
+7.22%
31.09B
Technology
Riot Platforms
5.04%
-0.37%
+0.96%
3.23B
Financial
PDD Holdings
5.01%
-0.24%
+2.28%
173.78B
Consumer Cyclical
Marvell
4.83%
-0.86%
+3.43%
56.89B
Technology
Celsius Holdings
4.43%
-0.05%
+2.09%
11.19B
Consumer Defensive
Block
4.15%
-0.88%
-0.21%
37.13B
Technology
Merck & Company
3.92%
-0.15%
+3.29%
317.26B
Healthcare
Based on the activity of 748,626 active portfolios
Open your Smart Portfolio

MLTX Investor Analysis

MLTX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
23.5%
of MLTX holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
MLTX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
35.3%
of MLTX holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
MLTX investors over 55

Over 55

3.1%
Last 30 days
Holdings Change
41.2%
of MLTX holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of MLTX stock investors
See who invests in MLTX according to age group and performance.

FAQ

How many retail Investors hold MLTX?
<0.1% of TipRanks' retail investors hold MLTX in their portfolios.
    What is MLTX Investor Sentiment?
    MLTX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of MLTX in the last 7 days?
      ▼ 1.9% of TipRanks' retail investors changed their holding of MLTX in the last 7 days.
        What percentage of retail investors changed their holding of MLTX in the last 30 days?
        ▼ 12.2% of TipRanks' retail investors changed their holding of MLTX in the last 30 days.
          What is the average age of retail investors who hold MLTX?
          The average age of MLTX Holders is over 55.
            What other stocks have MLTX investors also bought?
            MLTX Investors also bought DKNG, TTD, ZS, MSTR, RIOT, PDD, MRVL, CELH, SQ, MRK.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BAXBaxter International
              CRLCharles River Labs
              CORTCorcept Therapeutics
              CYTKCytokinetics
              DXCMDexcom
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis